Phelix AI Inc.

Phelix AI Inc. specializes in AI-driven healthcare automation solutions, enhancing efficiency in administrative workflows for healthcare providers. Its innovative platform significantly streamlines operations throughout the patient journey. Founded in 2018 in Toronto, Canada, Phelix AI Inc.

focuses on automating healthcare administration through its AI platform. The company was co-founded by Hassaan Ahmed, Karim Ramji, Sara Benbrahim, and Varun Pulapaka. It secured CAD 1 million in Seed funding in May 2020, with Well Health Technologies as a lead investor. Phelix AI has engaged in one deal to date, reflecting its focused approach to health tech innovation.

Phelix AI offers an AI-powered healthcare automation platform that streamlines administrative workflows such as triaging faxes, managing referrals, automating prior authorizations, and scheduling. Its solutions aim to alleviate the administrative workload on healthcare providers, thereby improving efficiency. The platform is compatible with existing Electronic Health Record (EHR) systems and is utilized by a wide range of clients, including primary care clinics and radiology centers mainly in the United States and Canada. Phelix AI generates revenue through subscription models, where healthcare organizations subscribe to access its automation tools.

The company collaborates with various clinics and healthcare providers, offering tiered pricing plans that cater to different needs, enabling scalability from small practices to larger healthcare networks. Key products include an AI-powered document processing API and automation tools for managing incoming faxes and referrals, emphasizing a business-to-business approach. Following its most recent deal in May 2020, Phelix AI plans to leverage the CAD 1 million raised to enhance its platform and expand into new markets. The focus will be on launching additional features aimed at improving patient processing times and enhancing overall service delivery.

Specific target markets include expanding its reach within the United States and exploring opportunities in Europe, with initiatives expected to roll out over the next 12 to 24 months.